Clinical Trials at Fred Hutch/University of Washington Cancer Consortium

As of June 2026, 101 paid clinical trials are recruiting at Fred Hutch/University of Washington Cancer Consortium in Seattle, Washington. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 3, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

101 clinical trials at Fred Hutch/University of Washington Cancer Consortium

·Clear filters·↓ Download CSV

Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms

for Acute Biphenotypic Leukemia

Drug: Venetoclax

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04797767·Phase 1, Phase 2·Recruiting

Apply to this trial

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

for Anatomic Stage I Breast Cancer AJCC v8

1 location in Seattle

Sponsor: University of Washington

Sex: Female·Age: 18+

Code: NCT05183828·Phase 4·Recruiting

Apply to this trial

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: Up to 50

Code: NCT03980769·Phase 2·Recruiting

Apply to this trial

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

for Castration-Resistant Prostate Carcinoma

4 locations incl. Baltimore

Sponsor: University of Washington

Sex: Male·Age: 18+

Code: NCT04489719·Recruiting

Apply to this trial

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

for Primary Myelofibrosis

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 70

Code: NCT04370301·Phase 2·Recruiting

Apply to this trial

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

for Acute Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months+·Accepts healthy volunteers

Code: NCT04195633·Phase 2·Recruiting

Apply to this trial

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

for Recurrent Acute Myeloid Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04375631·Phase 1·Recruiting

Apply to this trial

Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma

for Aggressive Non-Hodgkin Lymphoma

Drug: Polatuzumab Vedotin

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04231877·Phase 1·Recruiting

Apply to this trial

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

for Prostate Adenocarcinoma

2 locations incl. Pittsburgh

Sponsor: University of Washington

Sex: Male·Age: 18+

Code: NCT04175431·Phase 2·Recruiting

Apply to this trial

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

for Chronic Graft Versus Host Disease

9 locations incl. Gainesville

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18+

Code: NCT04431479·Recruiting

Apply to this trial

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

for Non-Malignant Neoplasm

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 49

Code: NCT04083183·Phase 1, Phase 2·Recruiting

Apply to this trial

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

for Prostate Carcinoma

8 locations incl. Duarte

Sponsor: University of Washington

Sex: Male·Age: 40+·Accepts healthy volunteers

Code: NCT04472338·Recruiting

Apply to this trial

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

for Acute Myeloid Leukemia

Drug: Ruxolitinib

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04282187·Phase 2·Recruiting

Apply to this trial

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for Acute Leukemia

3 locations incl. Tampa

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 1 - 60

Code: NCT03970096·Phase 2·Recruiting

Apply to this trial

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

for Metastatic Lung Non-Small Cell Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT04151940·Recruiting

Apply to this trial

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

for Acute Biphenotypic Leukemia

10 locations incl. Los Angeles

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 6 Months - 26·Accepts healthy volunteers

Code: NCT03779854·Phase 2·Recruiting

Apply to this trial

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

for Acute Lymphoblastic Leukemia in Remission

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT03670966·Phase 1, Phase 2·Recruiting

Apply to this trial

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

for Prostate Carcinoma

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: Male·Age: 35 - 89·Accepts healthy volunteers

Code: NCT04254133·Enrolling By Invitation

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

for Juvenile Myelomonocytic Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: Up to 80

Code: NCT03326921·Phase 1·Recruiting

Apply to this trial

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

for Acute Lymphoblastic Leukemia

1 location in Seattle

Sponsor: Fred Hutchinson Cancer Center

Sex: All·Age: 18 - 75

Code: NCT03128034·Phase 1, Phase 2·Recruiting

Apply to this trial

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for Localized Renal Pelvis and Ureter Urothelial Carcinoma

1 location in Seattle

Sponsor: University of Washington

Sex: Male·Age: 18+·Accepts healthy volunteers

Code: NCT01050504·Recruiting

Apply to this trial